5DS — MegaChem Income Statement
0.000.00%
- SG$56.65m
- SG$82.13m
- SG$124.41m
Annual income statement for MegaChem, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 139 | 144 | 123 | 129 | 124 |
| Cost of Revenue | |||||
| Gross Profit | 34.1 | 34.4 | 22.5 | 31.2 | 31.8 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 131 | 136 | 127 | 119 | 120 |
| Operating Profit | 8.37 | 8.09 | -4.47 | 9.38 | 4.51 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 9.19 | 7.83 | -5.34 | 8.69 | 4.27 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 7.99 | 6.07 | -5.8 | 7.91 | 3.91 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 7.76 | 5.88 | -5.91 | 7.91 | 3.83 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 7.76 | 5.88 | -5.91 | 7.91 | 3.83 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.056 | 0.044 | -0.048 | 0.055 | 0.029 |
| Dividends per Share |